Investor Relations

Investor Relations

We are a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with chronic kidney disease.

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Stock Chart

Events & Presentations

Date Title
09/09/19 at
8:45 AM EDT
Morgan Stanley 17th Annual Global Healthcare Conference
08/08/19 at
9:00 AM EDT
Second Quarter 2019 Financial Results
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet